Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Mangalam Drugs & Organics Revenue

In the fiscal year ending March 31, 2026, Mangalam Drugs & Organics had annual revenue of 2.32B INR, down -26.90%. Mangalam Drugs & Organics had revenue of 672.87M in the quarter ending March 31, 2026, a decrease of -7.54%.

• Revenue: 2.32B
• Revenue Growth: -26.90%
• P/S Ratio: 0.21
• Revenue / Employee: 4.84M
• Employees: 480
• Market Cap: 477.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.32B	-854.43M	-26.90%
Mar 31, 2025	3.18B	-497.78M	-13.55%
Mar 31, 2024	3.67B	-28.42M	-0.77%
Mar 31, 2023	3.70B	-806.66M	-17.89%
Mar 31, 2022	4.51B	708.84M	18.65%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error